ethylestrenol has been researched along with Myocardial Infarction in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, E; Hata, Y; Tsushima, M | 1 |
| Chakrabarti, R; Fearnley, GR | 1 |
| Chakrabarti, R | 1 |
| Chakrabarti, R; Fearnley, GR; Hocking, ED | 1 |
| Attwell, TN; Chakrabarti, R; Fearnley, GR; Hocking, ED; Jackson, D; Mann, RD | 1 |
| Naimi, S; Proger, S | 1 |
| Chakrabarti, R; Evans, JF; Fearnley, GR | 1 |
| Selye, H | 1 |
| Bruhn, HD; Jipp, P; Okoye, S; Oltmann, A | 1 |
| Sova, J | 1 |
| Menon, IS | 1 |
| Fearnley, GR | 2 |
2 trial(s) available for ethylestrenol and Myocardial Infarction
| Article | Year |
|---|---|
Primary prevention of atherosclerotic vascular disease with ethylnandrol. An interim report of four-year observations.
Topics: Adult; Aged; Arteriosclerosis; Aspartate Aminotransferases; Blood Pressure; Cholesterol; Clinical Trials as Topic; Ethylestrenol; Fibrinogen; Humans; Intracranial Embolism and Thrombosis; Japan; Male; Middle Aged; Myocardial Infarction; Placebos; Serum Globulins; Solubility; Triglycerides | 1975 |
Fibrinolytic effects of diguanides plus ethyloestrenol in occlusive vascular disease.
Topics: Adult; Aged; Angina Pectoris; Biguanides; Blood Coagulation Tests; Cholesterol; Ethylestrenol; Female; Fibrinogen; Humans; Intermittent Claudication; Male; Metformin; Middle Aged; Myocardial Infarction; Phenformin; Placebos; Vascular Diseases | 1967 |
11 other study(ies) available for ethylestrenol and Myocardial Infarction
| Article | Year |
|---|---|
Phenformin plus ethyloestrenol in survivors of myocardial infarction. Three-year pilot study.
Topics: Adult; Age Factors; Blood Platelets; Cholesterol; Drug Synergism; Ethylestrenol; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Phenformin; Potassium; Recurrence; Time Factors | 1972 |
Letter: Fibrinolytic activity and postoperative deep-vein thrombosis.
Topics: Ethylestrenol; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Phenformin; Postoperative Complications; Preoperative Care; Thrombophlebitis | 1974 |
Fibrinolytic activity and coronary-artery disease.
Topics: Adult; Age Factors; Aged; Blood Coagulation Disorders; Blood Coagulation Tests; Coronary Disease; Ethylestrenol; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Obesity; Phenformin | 1968 |
Fibrinolytic activity and coronary-artery disease.
Topics: Arteriosclerosis; Ethylestrenol; Fibrinolytic Agents; Humans; Myocardial Infarction; Phenformin | 1968 |
Effect of ethyloestrenol combined with phenformin or with metformin on platelet stickiness and serum-cholesterol in patients with occlusive vascular disease.
Topics: Aged; Anticholesteremic Agents; Blood Coagulation Tests; Blood Platelets; Butyrates; Cholesterol; Coronary Disease; Ethylestrenol; Female; Fibrinolysis; Humans; Intracranial Embolism and Thrombosis; Male; Metformin; Middle Aged; Myocardial Infarction; Phenformin; Vascular Diseases | 1968 |
Prevention of various forms of metabolic myocardial necrosis by catatoxic steroids.
Topics: Animals; Cardiomyopathies; Desoxycorticosterone; Digitoxin; Disease Models, Animal; Ethylestrenol; Female; Fludrocortisone; Myocardial Infarction; Necrosis; Norsteroids; Oxandrolone; Perchlorates; Prednisolone; Progesterone; Rats; Sodium; Spironolactone; Steroids; Triamcinolone | 1970 |
[Hypofibrinolysis in acute myocardial infarction (author's transl)].
Topics: Arterial Occlusive Diseases; Blood Coagulation Disorders; Ethylestrenol; Female; Fibrinolysis; Fibrinolytic Agents; Humans; Hydrocortisone; In Vitro Techniques; Male; Middle Aged; Myocardial Infarction; Phenformin; Plasminogen; Serum Globulins; Shock, Cardiogenic; Solubility; Urokinase-Type Plasminogen Activator | 1974 |
Immunologic study of fibrinogen and its split products in venous thrombosis.
Topics: Adult; Anticoagulants; Blood Cell Count; Blood Platelets; Ethyl Biscoumacetate; Ethylestrenol; Female; Fibrin; Fibrinogen; Fibrinolysis; Fluorescent Antibody Technique; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Neutrophils; Phagocytosis; Phenformin; Phlebography; Platelet Adhesiveness; Pulmonary Embolism; Pyrazoles; Thrombophlebitis; Time Factors | 1972 |
The role of phenformin and ethyloestrenol or stanozolol in the treatment of decreased fibrinolytic states. (Cutaneous vasculitis, Raynaud's disease, Behcet's syndrome, recurrent deep vein thrombosis and post myocardial infarction).
Topics: Administration, Oral; Adult; Amenorrhea; Anticoagulants; Behcet Syndrome; Drug Therapy, Combination; Ethylestrenol; Female; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Phenformin; Phlebitis; Raynaud Disease; Skin Diseases; Stanozolol; Thromboembolism; Thrombophlebitis; Varicose Ulcer | 1972 |
[Physiological and pharmacological aspects of fibrinolysis].
Topics: Adrenal Cortex Hormones; Anabolic Agents; Arteriosclerosis Obliterans; Biguanides; Blood Coagulation Tests; Blood Platelets; Clofibrate; Coronary Disease; Diabetes Mellitus; Ethylestrenol; Fibrinolysis; Humans; Insulin; Metformin; Myocardial Infarction; Phenformin; Sulfonylurea Compounds; Testosterone; Thrombosis | 1971 |
The fibrinolytic system.
Topics: Adult; Age Factors; Aged; Animals; Antifibrinolytic Agents; Drug Combinations; Ethylestrenol; Fibrinolysis; Humans; Middle Aged; Myocardial Infarction; Phenformin; Thrombosis; Time Factors | 1971 |